Biotech/Pharmaceutical News: 10 Pharmas Sidestep Procedures to Quicken Drug Development

By Alec Niedenthal  SEP 21, 2012 2:25 PM

Plus, Johnson & Johnson (NYSE:JNJ) opens new "innovation centers" to enhance productivity.


Here we present the most useful and interesting business news in biotechnology from across the web.

Link: Ten Pharmas Aim to Cut Red Tape to Speed Drug Development
 “Can cutting red tape and duplicated work help rein in the skyrocketing cost of developing new medicines? That’s the hope of a new company [being formed by] ten of the world’s biggest drug makers.

"The new outfit, Transcelerate Biopharma, was created out of a regular meeting of drug company research chiefs and will focus on five areas where the clinical trials that are used to test medicines wastefully duplicate procedures like training physicians, running websites, or creating procedures to document the benefits and side effects of new medicines.

No positions in stocks mentioned.